Search Results - "Oz, Mehmet C."

Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women: 2007 Update by Mosca, Lori, MD, MPH, PhD, Banka, Carole L., PhD, Benjamin, Emelia J., MD, Berra, Kathy, MSN, NP, Bushnell, Cheryl, MD, Dolor, Rowena J., MD, MHS, Ganiats, Theodore G., MD, Gomes, Antoinette S., MD, Gornik, Heather L., MD, MHS, Gracia, Clarissa, MD, MSCE, Gulati, Martha, MD, MS, Haan, Constance K., MD, Judelson, Debra R., MD, Keenan, Nora, PhD, Kelepouris, Ellie, MD, Michos, Erin D., MD, Newby, L. Kristin, MD, MHS, Oparil, Suzanne, MD, Ouyang, Pamela, MD, Oz, Mehmet C., MD, Petitti, Diana, MD, MPH, Pinn, Vivian W., MD, Redberg, Rita F., MD, MSc, Scott, Rosalyn, MD, Sherif, Katherine, MD, Smith, Sidney C., MD, Sopko, George, MD, MPH, Steinhorn, Robin H., MD, Stone, Neil J., MD, Taubert, Kathryn A., PhD, Todd, Barbara A., MSN, CRNP, Urbina, Elaine, MD, Wenger, Nanette K., MD

“…Some commonly used preventive interventions lacked clinical trial data for women, and it was unclear whether results of studies conducted in men could be…”
Get full text

Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart Failure by Rose, Eric A, Gelijns, Annetine C, Moskowitz, Alan J, Heitjan, Daniel F, Stevenson, Lynne W, Dembitsky, Walter, Long, James W, Ascheim, Deborah D, Tierney, Anita R, Levitan, Ronald G, Watson, John T, Ronan, Nuala S, Shapiro, Peter A, Lazar, Ronald M, Miller, Leslie W, Gupta, Lopa, Frazier, O. Howard, Desvigne-Nickens, Patrice, Oz, Mehmet C, Poirier, Victor L, Meier, Paul

“…Mechanical left ventricular assist devices have been used as a bridge to cardiac transplantation, but not as long-term therapy. In this study of patients with…”
Get full text

The effect of ischemic time on survival after heart transplantation varies by donor age: An analysis of the United Network for Organ Sharing database by Russo, Mark J., MD, MS, Chen, Jonathan M., MD, Sorabella, Robert A., BA, Martens, Timothy P., MD, Garrido, Mauricio, MD, Davies, Ryan R., MD, George, Isaac, MD, Cheema, Faisal H., MD, Mosca, Ralph S., MD, Mital, Seema, MD, Ascheim, Deborah D., MD, Argenziano, Michael, MD, Stewart, Allan S., MD, Oz, Mehmet C., MD, Naka, Yoshifumi, MD, PhD

“…Objectives (1) To examine the interaction of donor age with ischemic time and their effect on survival and (2) to define ranges of ischemic time associated…”
Get full text

Surgical ventricular restoration in the treatment of congestive heart failure due to post-infarction ventricular dilation by Athanasuleas, Constantine L., Buckberg, Gerald D., Stanley, Alfred W.H., Siler, William, Dor, Vincent, Di Donato, Marisa, Menicanti, Lorenzo, Almeida de Oliveira, Sergio, Beyersdorf, Friedhelm, Kron, Irving L., Suma, Hisayoshi, Kouchoukos, Nicholas T., Moore, Wistar, McCarthy, Patrick M., Oz, Mehmet C., Fontan, Francis, Scott, Meredith L., Accola, Kevin A.

“…The purpose of this study was to test how surgical ventricular restoration (SVR) affects early and late survival in a registry of 1,198 post-anterior…”
Get full text

Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness by KLOTZ, Stefan, FORONJY, Robert F, DICKSTEIN, Marc L, ANGUO GU, GARRELDS, Ingrid M, JAN DANSER, A. H, OZ, Mehmet C, D'ARMIENTO, Jeanine, BURKHOFF, Daniel

“…Left ventricular assist devices (LVADs) induce reverse remodeling of the failing heart except for the extracellular matrix, which exhibits additional…”
Get full text

Effect of Left Ventricular Assist Device Infection on Post-transplant Outcomes by Schulman, Allison R., BA, Martens, Timothy P., MD, Russo, Mark J., MD, MS, Christos, Paul J., MPH, MS, Gordon, Rachel J., MD, MPH, Lowy, Franklin D., MD, Oz, Mehmet C., MD, Naka, Yoshifumi, MD, PhD

“…Background In this study, we sought to confirm which types of device-related infections impact bridge-to-transplant rates. We also aimed to determine the…”
Get full text

Right ventricular dysfunction and organ failure in left ventricular assist device recipients: a continuing problem by Kavarana, Minoo N, Pessin-Minsley, Melissa S, Urtecho, Jacqueline, Catanese, Katharine A, Flannery, Margaret, Oz, Mehmet C, Naka, Yoshifumi

“…Background. Although right ventricular assist device (RVAD) use has declined with the introduction of inhaled nitric oxide and phosphodiesterase inhibitors…”
Get full text

The Cost of Medical Management in Advanced Heart Failure During the Final Two Years of Life by Russo, Mark J., MD, MS, Gelijns, Annetine C., PhD, Stevenson, Lynne W., MD, Sampat, Bhaven, PhD, Aaronson, Keith D., MD, Renlund, Dale G., MD, Ascheim, Deborah D., MD, Hong, Kimberly N., MHSA, Oz, Mehmet C., MD, MBA, Moskowitz, Alan J., MD, Rose, Eric A., MD, Miller, Leslie W., MD

“…Abstract Objective To examine patterns of resource use and the cost of care for patients with advanced heart failure treated with medical management (MM)…”
Get full text

Revised screening scale to predict survival after insertion of a left ventricular assist device by Rao, Vivek, Oz, Mehmet C., Flannery, Margaret A., Catanese, Katharine A., Argenziano, Michael, Naka, Yoshifumi

“…Background: We previously calculated a risk factor summation score that successfully predicted survival after insertion of a left ventricular assist device. We…”
Get full text

The Impact of Angiotensin-Converting Enzyme Inhibitor Therapy on the Extracellular Collagen Matrix During Left Ventricular Assist Device Support in Patients With End-Stage Heart Failure by Klotz, Stefan, MD, Danser, A.H. Jan, PhD, Foronjy, Robert F., MD, Oz, Mehmet C., MD, Wang, Jie, MD, PhD, Mancini, Donna, MD, D’Armiento, Jeanine, MD, PhD, Burkhoff, Daniel, MD, PhD

“…The Impact of Angiotensin-Converting Enzyme Inhibitor Therapy on the Extracellular Collagen Matrix During Left Ventricular Assist Device Support in Patients…”
Get full text

Clinical Indication for Use and Outcomes After Inhaled Nitric Oxide Therapy by George, Isaac, Xydas, Steve, Topkara, Veli K., Ferdinando, Corrina, Barnwell, Eileen C., Gableman, Larissa, Sladen, Robert N., Naka, Yoshifumi, Oz, Mehmet C.

“…Inhaled nitric oxide (iNO) use is widespread, but the long-term outcomes after therapy in adult patients remain unknown. All 376 patients receiving…”
Get full text

Association of device surface and biomaterials with immunologic sensitization after mechanical support by George, Isaac, MD, Colley, Patrick, BS, Russo, Mark J., MD, Martens, Timothy P., MD, Burke, Elizabeth, MS, Oz, Mehmet C., MD, Deng, Mario C., MD, Mancini, Donna M., MD, Naka, Yoshifumi, MD, PhD

“…Objective Biomaterials and textured surfaces in early pulsatile left ventricular assist devices (HeartMate I; Thoratec Corporation, Pleasanton, Calif) may…”
Get full text

Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure by HEERDT, Paul M, HOLMES, Jeffrey W, BOLIN CAI, BARBONE, Alessandro, MADIGAN, John D, REIKEN, Steven, LEE, David L, OZ, Mehmet C, MARKS, Andrew R, BURKHOFF, Daniel

“…Left ventricular (LV) assist devices (LVADs) can improve contractile strength and normalize characteristics of the Ca(2+) transient in myocytes isolated from…”
Get full text

Myocardial function improved by electromagnetic field induction of stress protein hsp70 by George, Isaac, Geddis, Matthew S., Lill, Zachary, Lin, Hana, Gomez, Teodoro, Blank, Martin, Oz, Mehmet C., Goodman, Reba

“…Studies on myocardial function have shown that hsp70, stimulated by an increase in temperature, leads to improved survival following ischemia‐reperfusion…”
Get full text

Vasopressin deficiency contributes to the vasodilation of septic shock by LANDRY, D. W, LEVIN, H. R, GALLANT, E. M, ASHTON, R. C, SEO, S, D'ALESSANDRO, D, OZ, M. C, OLIVER, J. A

“…The hypotension of septic shock is due to systemic vasodilation. On the basis of a clinical observation, we investigated the possibility that a deficiency in…”
Get full text

Controlled clinical trial of a novel hemostatic agent in cardiac surgery by Oz, Mehmet C, Cosgrove, Delos M, Badduke, Brian R, Hill, J.Donald, Flannery, Margaret R, Palumbo, Roberta, Topic, Nina

“…Background:. We performed a prospective randomized trial to compare FloSeal Matrix (Fusion Medical Technologies, Inc, Mountain View, CA), a gelatin-based…”
Get full text

A polymerized bovine hemoglobin oxygen carrier preserves regional myocardial function and reduces infarct size after acute myocardial ischemia by George, Isaac, Yi, Geng-Hua, Schulman, Allison R, Morrow, Brad T, Cheng, Yanping, Gu, Anguo, Zhang, Geping, Oz, Mehmet C, Burkhoff, Daniel, Wang, Jie

“…The purpose of this study was to test if HBOC-201, a hemoglobin-based oxygen-carrying solution, can decrease infarct size (or Inf) during acute, severe…”
Get more information

Discharge to Home Rates Are Significantly Lower for Octogenarians Undergoing Coronary Artery Bypass Graft Surgery by Bardakci, Hasmet, MD, Cheema, Faisal H., MD, Topkara, Veli K., MD, Dang, Nicholas C., MD, Martens, Timothy P., MD, Mercando, Michelle L, Forster, Catherine S, Benson, Ariel A, George, Isaac, MD, Russo, Mark J., MD, Oz, Mehmet C., MD, Esrig, Barry C., MD

“…Background The incidence of coronary artery bypass graft surgery (CABG) performed in elderly patients has been increasing over recent years. We sought to…”
Get full text

Appropriate timing of surgical intervention after transmural acute myocardial infarction by Lee, Daniel C., Oz, Mehmet C., Weinberg, Alan D., Ting, Windsor

“…Objective: Recommended timing of coronary revascularization after transmural acute myocardial infarction ranges from immediate surgical intervention to repair…”
Get full text

Multicenter review of preoperative risk factors for stroke after coronary artery bypass grafting by John, Ranjit, Choudhri, Asim F., Weinberg, Alan D., Ting, Windsor, Rose, Eric A., Smith, Craig R., Oz, Mehmet C.

“…Background. Stroke complicates the postoperative course in 1% to 6% of patients undergoing coronary revascularization. There has been no large scale mandatory…”
Get full text